GenVec to Present at the ROTH 23rd Annual Orange County Growth Stock Conference

Mar 08, 2011, 07:58 ET from GenVec, Inc.

GAITHERSBURG, Md., March 8, 2011 /PRNewswire/ -- GenVec, Inc. (Nasdaq:  GNVC) today announced that Douglas J. Swirsky, Senior Vice President and Chief Financial Officer, will present at the ROTH 23rd Annual Orange County Growth Stock Conference on Tuesday, March 15, 2011 at 3:30 p.m. PDT at the Ritz Carlton Laguna Niguel in Dana Point, CA.

A webcast of Mr. Swirsky's presentation will be available both live and on replay.  To access either the live or archived webcast, log on to GenVec's website at, click on "Investor Relations," and proceed to "Webcasts & Data".  The replay will be available 24 hours after the live presentation and will be accessible for 30 days.

About GenVec

GenVec, Inc. is a biopharmaceutical company using superior, proprietary technology to create differentiated vaccines and therapeutics that are developed and commercialized through collaborations. GenVec is working with leading companies and organizations such as Novartis, Merial, and the US Government to support a portfolio of product programs that address the prevention and treatment of a number of significant human and animal health concerns. GenVec's development programs address therapeutic areas such as hearing loss, balance disorders, and cancer; as well as vaccines against infectious diseases including respiratory syncytial virus (RSV), HSV-2, dengue fever, influenza, HIV, malaria, and foot-and-mouth disease. Additional information about GenVec is available at and in the Company's various filings with the Securities and Exchange Commission.

Investor and Media Contact:

GenVec, Inc.

Douglas J. Swirsky

(240) 632-5510

SOURCE GenVec, Inc.